N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142195 |
| CAS No | NA |
| Mol.F. | C12H14N4O4S |
| Mol.Wt. | 310.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142196 |
| CAS No | NA |
| Mol.F. | C12H14N4O5S |
| Mol.Wt. | 326.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142197 |
| CAS No | NA |
| Mol.F. | C10H12N4O3S |
| Mol.Wt. | 268.29 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142198 |
| CAS No | NA |
| Mol.F. | C9H8N4O3 |
| Mol.Wt. | 220.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142199 |
| CAS No | NA |
| Mol.F. | C10H10N4O3S |
| Mol.Wt. | 266.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142200 |
| CAS No | NA |
| Mol.F. | C9H7ClN4O3 |
| Mol.Wt. | 254.63 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142201 |
| CAS No | NA |
| Mol.F. | C15H18N4O4S |
| Mol.Wt. | 350.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142202 |
| CAS No | NA |
| Mol.F. | C12H14N4O4 |
| Mol.Wt. | 278.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142203 |
| CAS No | NA |
| Mol.F. | C9H6Cl2N4O3 |
| Mol.Wt. | 289.07 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142204 |
| CAS No | NA |
| Mol.F. | C13H16N4O3S |
| Mol.Wt. | 308.36 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142205 |
| CAS No | NA |
| Mol.F. | C12H14N4O3S |
| Mol.Wt. | 294.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142206 |
| CAS No | NA |
| Mol.F. | C9H8N4O3S |
| Mol.Wt. | 252.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142207 |
| CAS No | NA |
| Mol.F. | C10H11N3OS |
| Mol.Wt. | 221.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142208 |
| CAS No | NA |
| Mol.F. | C9H7ClN4O5S |
| Mol.Wt. | 318.69 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142209 |
| CAS No | NA |
| Mol.F. | C18H18N4O2 |
| Mol.Wt. | 322.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142210 |
| CAS No | NA |
| Mol.F. | C17H18N4O |
| Mol.Wt. | 294.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |